Sign In | Search | Help/FAQs
Cardiovascular Disease In Diabetes: The Silent Killer
Details
Expires Saturday November 6th, 2010
Price: $ FREE!Pre-Registration: Available
To register for this meeting, read the following disclosures and
then click the Enroll button at the bottom of the page.
Description

November 6, 2010 @ The Molly Blank Center on the campus of National Jewish Health

Cardiovascular disease is the number one killer of adults with diabetes mellitus. Cardiovascular disease is two to four times more common among adults with, than without diabetes. Even 'pre-diabetes' is a risk factor for cardiovascular disease. This seminar will review the most recent clinical evidence for preventing and managing cardiovascular disease among adults with pre-diabetes or overt diabetes mellitus.

Target Audience

Internal Medicine Physicians, Family Practitioners, Endocrinologists, Diabetes Educators, Dietitians, Physician Assistants, Nurse Practitioners, Cardiologists, and Nephrologists.

Register Now

Learning Objectives

  1. To understand the burden of cardio-vascular disease among the population of individuals with diabetes mellitus and 'pre-diabetes' mellitus.
  2. To review the newest clinical evidence for mitigating risk factors for cardio-vascular disease, specific to patients with diabetes
  3. To understand the utility of a stepped approach to pharmacologic therapy for hypertension and dyslipidemia among patients with diabetes.

Agenda

Time Topic Speaker
7:30 - 8:00am Registration  
8:00 - 8:15am Overview
  • Prevalence, morbidity, and mortality of CVD in diabetes
  • Translating the trial evidence into practice
 Elizabeth Kern, MD MS
8:15 - 8:45am Pre-diabetes and CVD risk
  • Defining pre-diabetes
  • Glycemia and CVD
  • Pharmacologic strategies
 TBD
8:45 - 9:30am Screening tests for CVD in the asymptomatic patient TBD
9:30 - 10:10am Break  
10:10 - 11:05am Treating hypertension
  • Salt intake and diuretics
  • RAAS inhibitors
  • Balancing Polypharmacy
 TBD
11:05am - 12:50pm Treating dyslipidemia
  • Statins
  • Fibrates
  • Goals of therapy - what have we learned from the clinical trials?
 TBD
12:50 - 1:20pm Panel Discussion (Q & A) All Speakers
1:20 - 1:30pm Closing Remarks Elizabeth Kern, MD MS

Register Now

Accreditation and Designation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this educational activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

National Jewish Health is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 12724. This program is being reviewed Nursing Contact Hours. Please check back soon for the exact number of Contact Hours to be awarded for your participation.

Participant attendance throughout the entire conference is required to receive contact hours.

Registration Fees

$60 - MDs and DOs
$40 - NPs, PAs, RNs, RDs, and Allied Health Professionals
$25 - National Jewish Health Staff

Register Now

Click here for a map of the National Jewish Health campus.

Faculty Disclosures
No disclosures provided.